Live Breaking News & Updates on Ompany 9939 Kyg5273b1077

Stay updated with breaking news from Ompany 9939 kyg5273b1077. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kintor Pharmaceutical : Pharma Announces Completion of First Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

Suzhou, April 14, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has. | April 14, 2023 ....

Yang Qinping , Kintor Pharma , Fudan University , Kintor Pharmaceutical Limited Pharma , Pharmaceutical Limited , Huashan Hospital , Chinese Androgenetic , Youzhi Tong , Chief Executive Officer , Kintor Pharmaceutical Limited Stock Exchange , Press Release , Ompany 9939 Kyg5273b1077 ,